NATCAPSUQ

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹220.4

-2.9% today · 30d +47.18%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for NATCAPSUQ. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹49 Cr

+7.76% YoY

NET PROFIT

₹-6 Cr

OPM

6.8%

+5.31pp YoY

EPS

₹-5.55

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.3% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

NATCAPSUQ—3.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 75

Valuation — —

Growth MUTED 44

Profitability AVERAGE 30

Technicals NEUTRAL 68

Risk LOW 90

Key Stats

P/B

0.97

52W HIGH

₹296.0

OFF HIGH

-25.54%

MKT CAP

₹229 Cr

◉ Active Signals

MACDBullish5.818

RSI(14)Bearish73.33

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NATCAPSUQ and at what entry.